SYS | | c008836 |
LBL | | ^^^^^nam^^22^^^^^^^^450^ |
005 | | 20130408181420.2 |
010 | | $a 1-55664-233-4 |
100 | | $a 19940913d1991 u y0sloc0103 ba |
101 | 0- | $a eng |
102 | | $a US |
105 | | $a a z 000yy |
200 | 1- | $a Introduction to clinical medicine $f edit. Harry L. Greene, Richard J. Glassock, Mark A. Kelley |
210 | | $a Philadelphia $c Decker $d 1991 |
215 | | $a x, 794 s. $c il. |
541 | 1- | $a Uvedenie do klinickej medicíny $z slo |
606 | | $a lekárstvo klinické $2 mesh $3 sllk_un_auth*d015510 |
606 | | $a genetika $2 mesh $3 sllk_un_auth*d005823 |
606 | | $a diagnostika počítačová $2 mesh $3 sllk_un_auth*d003936 |
606 | | $a ošetrovateľstvo $2 mesh $3 sllk_un_auth*d009729 |
606 | | $a dietoterapia $2 mesh $3 sllk_un_auth*d004035 |
606 | | $3 sllk_un_auth*d026761 $a fyzioterapia (špecializácia) $2 mesh |
606 | | $a terapia pracovná $2 mesh $3 sllk_un_auth*d009788 |
606 | | $a dietoterapia $2 mesh $3 sllk_un_auth*d004035 |
606 | | $3 sllk_un_auth*d012946 $a starostlivosť sociálna verejná $2 mesh |
606 | | $3 sllk_un_auth*d019411 $a techniky klinické laboratórne $2 mesh |
606 | | $3 sllk_un_auth*d003585 $a biológia bunková $2 mesh |
606 | | $a biopsia $2 mesh $3 sllk_un_auth*d001706 |
606 | | $a reakcia na dávku lieku $2 mesh $3 sllk_un_auth*d004305 |
606 | | $3 sllk_un_auth*d004347 $a interakcie liekové $2 mesh |
606 | | $a lekárstvo nukleárne $2 mesh $3 sllk_un_auth*d009683 |
606 | | $a MRI $2 mesh $3 sllk_un_auth*d008279 |
606 | | $a choroby kardiovaskulárne $2 mesh $3 sllk_un_auth*d002318 |
606 | | $a choroby endokrinného systému $2 mesh $3 sllk_un_auth*d004700 |
606 | | $a neurológia $2 mesh $3 sllk_un_auth*d009462 |
606 | | $a onkológia lekárska $2 mesh $3 sllk_un_auth*d008495 |
675 | | $a 616.1/.9 $v 1. stred. $z slo |
702 | -1 | $a Greene $b Harry L. $3 sllk_un_auth*p0013697 $4 340 |
702 | -1 | $a Glassock $b Richard J. $3 sllk_un_auth*p0006989 $4 340 |
702 | -1 | $a Kelley $b Mark A. $3 sllk_un_auth*p0013698 $4 340 |
801 | -0 | $a SK $b BA006 $c 19981223 $g AACR2 |